by
Barbara Kram, Editor | October 01, 2007
The Nielsen Company
is a global
information and
media company.
September 27, 2007, New York City - The Nielsen Company has announced the launch of Diabetes*Buzz(tm) and Healthcare Marketing Mix, two new services of NielsenHealth that bring together the capabilities of Nielsen's broad array of health-related services. These products were developed to meet the needs of pharmaceutical and OTC product manufacturers, healthcare retailers such as large pharmacy chains, healthcare provider organizations, and advertising agencies engaged in
healthcare media.
"Diabetes*Buzz and Healthcare Marketing Mix will provide unique, specialized insights into healthcare consumer attitudes and behaviors," said Matt Dumas, Managing Director, NielsenHealth. "Among many uses we envision with these services, Diabetes*Buzz, for example, will enable those involved in health state management a greater understanding of patient experiences and attitudes to ultimately enhance patient care. Additionally, with both Diabetes*Buzz and Healthcare Marketing Mix, healthcare providers, manufacturers, pharmacies and other pharmacy retailers will have more relevant information to better serve the needs of their consumers."

Ad Statistics
Times Displayed: 109380
Times Visited: 6640 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
Diabetes*Buzz
Diabetes*Buzz is the only research mechanism available focused solely on continuously monitoring the current perceptions and attitudes of diabetes and its impact on patient lifestyle. Using Nielsen BuzzMetrics' advanced Internet-tracking technology, Diabetes*Buzz scours
tens of thousands of consumer-generated messages on the Internet to provide critical insights into attitudes, online discussion volume and
sentiments. The service additionally uses brand mapping to help determine ongoing patient and caregiver issues and concerns. Diabetes*Buzz will also integrate sales data for products and issues
across major diabetes categories, including pharmaceutical (Rx) therapy, testing supplies, vitamins and supplements.
According to the U.S. Centers for Disease Control (CDC) diabetes is the sixth leading cause of death in U.S. The CDC estimates 20.8 million
children and adults in the United States, or 7 percent of the population, have diabetes, with an estimated 1.5 million new cases diagnosed each year.
"Helping our clients in the healthcare space better understand diabetes from the perspective of patients and caregivers is incredibly important.
Diabetes*Buzz provides a key link in building that understanding," said Melissa Davies, Research Director-Healthcare, Nielsen BuzzMetrics.